AtriCure ATRC Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $108K+102% | —— | -$267K+96.6% | -$6.19M+22.7% | -$6.75M+49.2% | ||
| $2.89M-2.9% | $3M+1.9% | $3.06M+0.6% | $3.06M+15.8% | $2.97M+14.9% | ||
| $11.27M+17.1% | $11.26M+8.4% | $12.42M+19.9% | $11.37M+9.4% | $9.63M+3.9% | ||
| $105K-12.5% | $119K0.0% | $120K0.0% | $119K+88.9% | $120K-31.8% | ||
| $5.02M+86.9% | $3.76M-38.1% | —— | $2.16M+531% | $2.69M-3.7% | ||
| $2.77M+469% | —— | $2.64M-1.8% | $824K-52.7% | -$750K-118% | ||
| $5.57M+872% | -$1.28M+77.9% | $360K-91.5% | —— | -$722K-134% | ||
| -$13.51M-7.5% | $3.71M-37.8% | $9.12M— | $6.73M— | -$12.56M+15.6% | ||
| $708K+43.0% | $648K-55.3% | $415K+117% | —— | $495K+161% | ||
| $2.38M+13.0% | $2.11M+11.9% | $2.11M+11.9% | $2.11M+12.0% | $2.11M+13.3% | ||
| $5.16M+32.9% | —— | $205K+109% | —— | $3.89M+12.3% | ||
| -$4M+63.8% | $20.03M+243% | $26.72M+33.6% | $21.62M+193% | -$11.03M+47.5% | ||
| $3.85M+76.6% | $1.6M-40.5% | $2.61M-27.8% | $2.66M+11.7% | $2.18M-21.4% | ||
| -$3.85M-129% | -$2.6M— | -$2.61M-159% | -$7.66M-125% | -$1.68M-117% | ||
| $1.19M+316% | $321K+14.2% | $301K+11.9% | $292K+10.6% | $287K-99.5% | ||
| $11.44M+12.5% | $228K+18.8% | $357K+467% | $406K+155% | $10.17M+55.6% | ||
| $777K— | $0— | $0-100% | $0-100% | $0-100% | ||
| -$13.26M-28.4% | $2.1M— | —— | —— | -$10.33M-31.3% | ||
| -$160K-182% | $40K+108% | $0-100% | $537K+1,042% | $196K+280% | ||
| -$21.26M+6.9% | $19.56M— | $30.07M+23.7% | $17.91M-56.4% | -$22.84M-18.1% | ||
| $1.22M-2.1% | $1.34M-43.1% | $1.35M-5.7% | $1.33M-8.4% | $1.25M+71.6% | ||
| $91K-21.6% | —— | $748K+1,016% | $766K+55.7% | $116K+582% | ||
| $105K-12.5% | $119K0.0% | $120K0.0% | $119K+88.9% | $120K-31.8% | ||
| $2.38M+13.0% | $2.11M+11.9% | $2.11M+11.9% | $2.11M+12.0% | $2.11M+13.3% | ||
| $2.89M-2.9% | $3M+1.9% | $3.06M+0.6% | $3.06M+15.8% | $2.97M+14.9% | ||
| $5.16M+32.9% | —— | $205K+109% | —— | $3.89M+12.3% | ||
| $575K+14.1% | $352K+26.2% | $776K+326% | $497K+7.3% | $504K+350% | ||
| $777K— | $0— | $0-100% | $0-100% | $0-100% | ||
| $1.19M+316% | $321K+14.2% | $301K+11.9% | $292K+10.6% | $287K-99.5% | ||
| $0-100% | —— | —— | —— | $500K— | ||
| $158K+17.9% | —— | $392K+494% | $4.12M+20.4% | $134K-65.6% | ||
| $91K-21.6% | —— | $748K+1,016% | $766K+55.7% | $116K+582% | ||
| -$7.85M+40.6% | $18.43M+486% | $24.11M— | $18.96M— | -$13.21M+44.5% | ||
| -$7.85M+40.6% | $18.43M+486% | $24.11M— | $18.96M— | -$13.21M+44.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AtriCure generate?
- AtriCure (ATRC) generated $64.4M in operating cash flow over the trailing twelve months.
- What is AtriCure's free cash flow?
- After $10.7M of capital expenditures, AtriCure's free cash flow was $53.6M over the trailing twelve months, up 249.2% year over year.
- Where does AtriCure's cash flow data come from?
- Every line is extracted from AtriCure's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
